Skip to main content

Table 5 Improvement in MACE risk reclassification

From: Incremental predictive value of liver fat fraction based on spectral detector CT for major adverse cardiovascular events in T2DM patients with suspected coronary artery disease

Model

Variables

NRI (95%CI)

p

IDI (95%CI)

p

C-index

Model A

FRS

–

–

–

–

0.562

Model B

FRS + CACS

0.261(0.106–0.417) VS. Model A

<0.01*

0.034(0.005–0.098) VS. Model A

0.01*

0.634

Model C

FRS + CACS + LFF

0.397(0.187–0.528) VS. Model A

0.367(0.158–0.510) VS. Model B

<0.01*

0.01*

0.100(0.043–0.190)

VS. Model A

0.066(0.024–0.130)

VS. Model B

<0.01*

<0.01*

0.725

Model D

FRS + CACS + LFF + Obstructive stenosis + Early revascularization

0.451(0.280–0.580) VS. Model A

0.432(0.253–0.586) VS. Model B

0.048(-0.103-0.381)

VS. Model C

<0.01*

<0.01*

0.348

0.185(0.101–0.308)

VS. Model A

0.151(0.083–0.249)

VS. Model B

0.085(0.025–0.147)

VS. Model C

<0.01*

<0.01*

<0.01*

0.770

  1. * p <0.05.
  2. MACE, major adverse cardiovascular events; NRI, Net Reclassification Index; IDI, Integrated Discrimination Index; CI, confidence interval; FRS, Framingham Risk Score; CACS, coronary artery calcium score; LFF, liver fat fraction